Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ramirent in connection with its acquisition of JIAB
Mandate

Vinge advises Ramirent in connection with its acquisition of JIAB

March 21, 2023 Banking and Finance M&A Corporate Commercial IT, Telecommunications and Outsourcing Intellectual Property Real Estate and Construction

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.

Vinge’s team mainly consist of Jonas Johansson, Per Kling, Elsie Nassar and Nando Basic (M&A), Arvid Axelryd and Emma Gustavsson (IPR), Seyran Sahin and Ida Redander (Banking and finance), Anna Ståhlklo, Anna Högsten and Maja Eliasson (Employment), Martin Boström and Mario Saad (Corporate commercial), Karolina Fuhrman and Elis Allmark (IT & GDPR), Tove Tullberg and Julia Löfqvist (compliance), Rebecka Maltenius (real estate), and Emy Rydén and Ellinore Boström Andersson (project assistants).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025